Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 276

1.

Patient-reported burden of intensified surveillance and surgery in high-risk individuals under pancreatic cancer surveillance.

Overbeek KA, Cahen DL, Kamps A, Konings ICAW, Harinck F, Kuenen MA, Koerkamp BG, Besselink MG, van Eijck CH, Wagner A, Ausems MGE, van der Vlugt M, Fockens P, Vleggaar FP, Poley JW, van Hooft JE, Bleiker EMA, Bruno MJ; Dutch Familial Pancreatic Cancer Surveillance Study Group.

Fam Cancer. 2020 Mar 19. doi: 10.1007/s10689-020-00171-8. [Epub ahead of print]

PMID:
32193697
2.

C-reactive protein is superior to white blood cell count for early detection of complications after pancreatoduodenectomy: a retrospective multicenter cohort study.

van Dongen JC, Smits FJ, van Santvoort HC, Molenaar IQ, Busch OR, Besselink MG, Aziz MH, Groot Koerkamp B, van Eijck CHJ; Dutch Pancreatic Cancer Group.

HPB (Oxford). 2020 Mar 11. pii: S1365-182X(20)30055-1. doi: 10.1016/j.hpb.2020.02.005. [Epub ahead of print]

PMID:
32171648
3.

Serum miR-338-3p and miR-199b-5p are associated with the absolute neutrophil count in patients with resectable pancreatic cancer.

van der Sijde F, Vietsch EE, Mustafa DAM, Li Y, van Eijck CHJ.

Clin Chim Acta. 2020 Mar 4;505:183-189. doi: 10.1016/j.cca.2020.03.005. [Epub ahead of print]

PMID:
32145274
4.

Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial.

Versteijne E, Suker M, Groothuis K, Akkermans-Vogelaar JM, Besselink MG, Bonsing BA, Buijsen J, Busch OR, Creemers GM, van Dam RM, Eskens FALM, Festen S, de Groot JWB, Groot Koerkamp B, de Hingh IH, Homs MYV, van Hooft JE, Kerver ED, Luelmo SAC, Neelis KJ, Nuyttens J, Paardekooper GMRM, Patijn GA, van der Sangen MJC, de Vos-Geelen J, Wilmink JW, Zwinderman AH, Punt CJ, van Eijck CH, van Tienhoven G; Dutch Pancreatic Cancer Group.

J Clin Oncol. 2020 Feb 27:JCO1902274. doi: 10.1200/JCO.19.02274. [Epub ahead of print]

PMID:
32105518
5.

Establishing and Coordinating a Nationwide Multidisciplinary Study Group: Lessons Learned by the Dutch Pancreatic Cancer Group.

Strijker M, Mackay TM, Bonsing BA, Bruno MJ, van Eijck CHJ, de Hingh IHJT, Koerkamp BG, van Laarhoven HW, Molenaar IQ, van Santvoort HC, van Tienhoven G, Wilmink JW, Zeverijn S, Busch OR, Besselink MG.

Ann Surg. 2020 Apr;271(4):e102-e104. doi: 10.1097/SLA.0000000000003779. No abstract available.

PMID:
32084037
6.

Neoadjuvant Treatment in Patients With Resectable and Borderline Resectable Pancreatic Cancer.

Janssen QP, O'Reilly EM, van Eijck CHJ, Groot Koerkamp B.

Front Oncol. 2020 Jan 31;10:41. doi: 10.3389/fonc.2020.00041. eCollection 2020.

7.

HHLA2 is expressed in pancreatic and ampullary cancers and increased expression is associated with better post-surgical prognosis.

Boor PPC, Sideras K, Biermann K, Hosein Aziz M, Levink IJM, Mancham S, Erler NS, Tang X, van Eijck CH, Bruno MJ, Sprengers D, Zang X, Kwekkeboom J.

Br J Cancer. 2020 Feb 19. doi: 10.1038/s41416-020-0755-4. [Epub ahead of print]

PMID:
32071413
8.

Implementation of contemporary chemotherapy for patients with metastatic pancreatic ductal adenocarcinoma: a population-based analysis.

Latenstein AEJ, Mackay TM, Creemers GJ, van Eijck CHJ, de Groot JWB, Haj Mohammad N, Homs MYV, van Laarhoven HWM, Molenaar IQ, Ten Tije BJ, de Vos-Geelen J, Besselink MG, van der Geest LGM, Wilmink JW; Dutch Pancreatic Cancer Group.

Acta Oncol. 2020 Feb 14:1-8. doi: 10.1080/0284186X.2020.1725241. [Epub ahead of print]

PMID:
32056483
9.

Conditional Survival After Resection for Pancreatic Cancer: A Population-Based Study and Prediction Model.

Latenstein AEJ, van Roessel S, van der Geest LGM, Bonsing BA, Dejong CHC, Groot Koerkamp B, de Hingh IHJT, Homs MYV, Klaase JM, Lemmens V, Molenaar IQ, Steyerberg EW, Stommel MWJ, Busch OR, van Eijck CHJ, van Laarhoven HWM, Wilmink JW, Besselink MG; Dutch Pancreatic Cancer Group.

Ann Surg Oncol. 2020 Feb 12. doi: 10.1245/s10434-020-08235-w. [Epub ahead of print]

PMID:
32052299
10.

Effect of Early Surgery vs Endoscopy-First Approach on Pain in Patients With Chronic Pancreatitis: The ESCAPE Randomized Clinical Trial.

Issa Y, Kempeneers MA, Bruno MJ, Fockens P, Poley JW, Ahmed Ali U, Bollen TL, Busch OR, Dejong CH, van Duijvendijk P, van Dullemen HM, van Eijck CH, van Goor H, Hadithi M, Haveman JW, Keulemans Y, Nieuwenhuijs VB, Poen AC, Rauws EA, Tan AC, Thijs W, Timmer R, Witteman BJ, Besselink MG, van Hooft JE, van Santvoort HC, Dijkgraaf MG, Boermeester MA; Dutch Pancreatitis Study Group.

JAMA. 2020 Jan 21;323(3):237-247. doi: 10.1001/jama.2019.20967.

PMID:
31961419
11.

International validation and update of the Amsterdam model for prediction of survival after pancreatoduodenectomy for pancreatic cancer.

van Roessel S, Strijker M, Steyerberg EW, Groen JV, Mieog JS, Groot VP, He J, De Pastena M, Marchegiani G, Bassi C, Suhool A, Jang JY, Busch OR, Halimi A, Zarantonello L, Groot Koerkamp B, Samra JS, Mittal A, Gill AJ, Bolm L, van Eijck CH, Abu Hilal M, Del Chiaro M, Keck T, Alseidi A, Wolfgang CL, Malleo G, Besselink MG.

Eur J Surg Oncol. 2019 Dec 28. pii: S0748-7983(19)31519-7. doi: 10.1016/j.ejso.2019.12.023. [Epub ahead of print]

PMID:
31924432
12.

Efficacy and feasibility of stereotactic radiotherapy after folfirinox in patients with locally advanced pancreatic cancer (LAPC-1 trial).

Suker M, Nuyttens JJ, Eskens FALM, Haberkorn BCM, Coene PLO, van der Harst E, Bonsing BA, Vahrmeijer AL, Mieog JSD, Jan Swijnenburg R, Roos D, Koerkamp BG, van Eijck CHJ.

EClinicalMedicine. 2019 Nov 19;17:100200. doi: 10.1016/j.eclinm.2019.10.013. eCollection 2019 Dec.

13.

Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma.

Latenstein AEJ, van der Geest LGM, Bonsing BA, Groot Koerkamp B, Haj Mohammad N, de Hingh IHJT, de Meijer VE, Molenaar IQ, van Santvoort HC, van Tienhoven G, Verheij J, Vissers PAJ, de Vos-Geelen J, Busch OR, van Eijck CHJ, van Laarhoven HWM, Besselink MG, Wilmink JW; Dutch Pancreatic Cancer Group.

Eur J Cancer. 2020 Jan;125:83-93. doi: 10.1016/j.ejca.2019.11.002. Epub 2019 Dec 13.

14.

Early recognition of clinically relevant postoperative pancreatic fistula: a systematic review.

Smits FJ, Molenaar IQ, Besselink MG, Borel Rinkes IHM, van Eijck CHJ, Busch OR, van Santvoort HC; Dutch Pancreatic Cancer Group.

HPB (Oxford). 2020 Jan;22(1):1-11. doi: 10.1016/j.hpb.2019.07.005. Epub 2019 Aug 21. Review.

PMID:
31445782
15.

The risk of not receiving adjuvant chemotherapy after resection of pancreatic ductal adenocarcinoma: a nationwide analysis.

Mackay TM, Smits FJ, Roos D, Bonsing BA, Bosscha K, Busch OR, Creemers GJ, van Dam RM, van Eijck CHJ, Gerhards MF, de Groot JWB, Groot Koerkamp B, Haj Mohammad N, van der Harst E, de Hingh IHJT, Homs MYV, Kazemier G, Liem MSL, de Meijer VE, Molenaar IQ, Nieuwenhuijs VB, van Santvoort HC, van der Schelling GP, Stommel MWJ, Ten Tije AJ, de Vos-Geelen J, Wit F, Wilmink JW, van Laarhoven HWM, Besselink MG; Dutch Pancreatic Cancer Group.

HPB (Oxford). 2020 Feb;22(2):233-240. doi: 10.1016/j.hpb.2019.06.019. Epub 2019 Aug 19.

PMID:
31439478
16.

The role of abdominal drainage in pancreatic resection - A multicenter validation study for early drain removal.

Linnemann RJA, Patijn GA, van Rijssen LB, Besselink MG, Mungroop TH, de Hingh IH, Kazemier G, Festen S, de Jong KP, van Eijck CHJ, Scheepers JJG, van der Kolk M, Dulk MD, Bosscha K, Busch OR, Boerma D, van der Harst E, Nieuwenhuijs VB; Dutch Pancreatic Cancer Group.

Pancreatology. 2019 Sep;19(6):888-896. doi: 10.1016/j.pan.2019.07.041. Epub 2019 Jul 27.

PMID:
31378583
17.

Locally Advanced Pancreatic Cancer: Work-Up, Staging, and Local Intervention Strategies.

van Veldhuisen E, van den Oord C, Brada LJ, Walma MS, Vogel JA, Wilmink JW, Del Chiaro M, van Lienden KP, Meijerink MR, van Tienhoven G, Hackert T, Wolfgang CL, van Santvoort H, Groot Koerkamp B, Busch OR, Molenaar IQ, van Eijck CH, Besselink MG; Dutch Pancreatic Cancer Group and International Collaborative Group on Locally Advanced Pancreatic Cancer.

Cancers (Basel). 2019 Jul 12;11(7). pii: E976. doi: 10.3390/cancers11070976. Review.

18.

[Is surgical treatment of pulmonary metastases justified?]

Detillon DEMA, van Eijck CHJ, Veen EJ.

Ned Tijdschr Geneeskd. 2019 Jun 19;163. pii: D4083. Dutch.

PMID:
31283125
19.

Predicting Successful Catheter Drainage in Patients With Pancreatic Fistula After Pancreatoduodenectomy.

Smits FJ, van Santvoort HC, Besselink MG, Boerma D, Busch OR, van Dam RM, van Eijck CH, Festen S, van der Harst E, de Hingh IH, de Jong KP, Borel Rinkes IH, Molenaar IQ; Dutch Pancreatic Cancer Group.

Pancreas. 2019 Jul;48(6):811-816. doi: 10.1097/MPA.0000000000001334.

PMID:
31210662
20.

Yield of staging laparoscopy before treatment of locally advanced pancreatic cancer to detect occult metastases.

Suker M, Koerkamp BG, Coene PP, van der Harst E, Bonsing BA, Vahrmeijer AL, Mieog JSD, Swijnenburg RJ, Dwarkasing RS, Roos D, van Eijck CHJ.

Eur J Surg Oncol. 2019 Oct;45(10):1906-1911. doi: 10.1016/j.ejso.2019.06.004. Epub 2019 Jun 3.

PMID:
31186205
21.

Search for Early Pancreatic Cancer Blood Biomarkers in Five European Prospective Population Biobanks Using Metabolomics.

Fest J, Vijfhuizen LS, Goeman JJ, Veth O, Joensuu A, Perola M, Männistö S, Ness-Jensen E, Hveem K, Haller T, Tonisson N, Mikkel K, Metspalu A, van Duijn CM, Ikram A, Stricker BH, Ruiter R, van Eijck CHJ, van Ommen GB, ʼt Hoen PAC.

Endocrinology. 2019 Jul 1;160(7):1731-1742. doi: 10.1210/en.2019-00165.

22.

Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis.

Janssen QP, Buettner S, Suker M, Beumer BR, Addeo P, Bachellier P, Bahary N, Bekaii-Saab T, Bali MA, Besselink MG, Boone BA, Chau I, Clarke S, Dillhoff M, El-Rayes BF, Frakes JM, Grose D, Hosein PJ, Jamieson NB, Javed AA, Khan K, Kim KP, Kim SC, Kim SS, Ko AH, Lacy J, Margonis GA, McCarter MD, McKay CJ, Mellon EA, Moorcraft SY, Okada KI, Paniccia A, Parikh PJ, Peters NA, Rabl H, Samra J, Tinchon C, van Tienhoven G, van Veldhuisen E, Wang-Gillam A, Weiss MJ, Wilmink JW, Yamaue H, Homs MYV, van Eijck CHJ, Katz MHG, Groot Koerkamp B.

J Natl Cancer Inst. 2019 Aug 1;111(8):782-794. doi: 10.1093/jnci/djz073.

PMID:
31086963
23.

Clinical Trials Targeting the Stroma in Pancreatic Cancer: A Systematic Review and Meta-Analysis.

van Mackelenbergh MG, Stroes CI, Spijker R, van Eijck CHJ, Wilmink JW, Bijlsma MF, van Laarhoven HWM.

Cancers (Basel). 2019 Apr 26;11(5). pii: E588. doi: 10.3390/cancers11050588. Review.

24.

Postponed or immediate drainage of infected necrotizing pancreatitis (POINTER trial): study protocol for a randomized controlled trial.

van Grinsven J, van Dijk SM, Dijkgraaf MG, Boermeester MA, Bollen TL, Bruno MJ, van Brunschot S, Dejong CH, van Eijck CH, van Lienden KP, Boerma D, van Duijvendijk P, Hadithi M, Haveman JW, van der Hulst RW, Jansen JM, Lips DJ, Manusama ER, Molenaar IQ, van der Peet DL, Poen AC, Quispel R, Schaapherder AF, Schoon EJ, Schwartz MP, Seerden TC, Spanier BWM, Straathof JW, Venneman NG, van de Vrie W, Witteman BJ, van Goor H, Fockens P, van Santvoort HC, Besselink MG; Dutch Pancreatitis Study Group.

Trials. 2019 Apr 25;20(1):239. doi: 10.1186/s13063-019-3315-6.

25.

The systemic immune-inflammation index is associated with an increased risk of incident cancer-A population-based cohort study.

Fest J, Ruiter R, Mulder M, Groot Koerkamp B, Ikram MA, Stricker BH, van Eijck CHJ.

Int J Cancer. 2020 Feb 1;146(3):692-698. doi: 10.1002/ijc.32303. Epub 2019 Apr 16.

26.

Video-assisted thoracic lobectomy versus stereotactic body radiotherapy for stage I nonsmall cell lung cancer in elderly patients: a propensity matched comparative analysis.

Detillon DDEMA, Aarts MJ, De Jaeger K, Van Eijck CHJ, Veen EJ.

Eur Respir J. 2019 Jun 20;53(6). pii: 1801561. doi: 10.1183/13993003.01561-2018. Print 2019 Jun.

PMID:
30923188
27.

Sublingual microcirculation in pancreatico-biliary surgery: An observational study.

Suker M, Tovar Doncel MS, Pinto Lima AA, Ince C, van Eijck CHJ.

Clin Hemorheol Microcirc. 2019;72(3):247-257. doi: 10.3233/CH-180448.

PMID:
30856105
28.

Systematic review of clinical prediction models for survival after surgery for resectable pancreatic cancer.

Strijker M, Chen JW, Mungroop TH, Jamieson NB, van Eijck CH, Steyerberg EW, Wilmink JW, Groot Koerkamp B, van Laarhoven HW, Besselink MG.

Br J Surg. 2019 Mar;106(4):342-354. doi: 10.1002/bjs.11111. Epub 2019 Feb 13.

PMID:
30758855
29.

Parathyroidectomy versus cinacalcet for tertiary hyperparathyroidism; a retrospective analysis.

Dulfer RR, Koh EY, van der Plas WY, Engelsman AF, van Dijkum EJMN, Pol RA, Vogt L, de Borst MH, Kruijff S, Schepers A, Appelman-Dijkstra NM, Rotmans JI, Hesselink DA, van Eijck CHJ, Hoorn EJ, van Ginhoven TM; Dutch Hyperparathyroid Study Group.

Langenbecks Arch Surg. 2019 Feb;404(1):71-79. doi: 10.1007/s00423-019-01755-4. Epub 2019 Feb 7.

30.

Circulating Biomarkers for Prediction of Objective Response to Chemotherapy in Pancreatic Cancer Patients.

van der Sijde F, Vietsch EE, Mustafa DAM, Besselink MG, Groot Koerkamp B, van Eijck CHJ.

Cancers (Basel). 2019 Jan 15;11(1). pii: E93. doi: 10.3390/cancers11010093. Review.

31.

The neutrophil-to-lymphocyte ratio is associated with mortality in the general population: The Rotterdam Study.

Fest J, Ruiter TR, Groot Koerkamp B, Rizopoulos D, Ikram MA, van Eijck CHJ, Stricker BH.

Eur J Epidemiol. 2019 May;34(5):463-470. doi: 10.1007/s10654-018-0472-y. Epub 2018 Dec 19.

32.

Erythrocyte sedimentation rate as an independent prognostic marker for mortality: a prospective population-based cohort study.

Fest J, Ruiter R, Mooijaart SP, Ikram MA, van Eijck CHJ, Stricker BH.

J Intern Med. 2019 Mar;285(3):341-348. doi: 10.1111/joim.12853. Epub 2018 Dec 9.

PMID:
30537394
33.

Patients with chronic mesenteric ischemia have an altered sublingual microcirculation.

Harki J, Suker M, Tovar-Doncel MS, van Dijk LJ, van Noord D, van Eijck CH, Bruno MJ, Kuipers EJ, Ince C.

Clin Exp Gastroenterol. 2018 Oct 18;11:405-414. doi: 10.2147/CEG.S159160. eCollection 2018.

34.

Superiority of Step-up Approach vs Open Necrosectomy in Long-term Follow-up of Patients With Necrotizing Pancreatitis.

Hollemans RA, Bakker OJ, Boermeester MA, Bollen TL, Bosscha K, Bruno MJ, Buskens E, Dejong CH, van Duijvendijk P, van Eijck CH, Fockens P, van Goor H, van Grevenstein WM, van der Harst E, Heisterkamp J, Hesselink EJ, Hofker S, Houdijk AP, Karsten T, Kruyt PM, van Laarhoven CJ, Laméris JS, van Leeuwen MS, Manusama ER, Molenaar IQ, Nieuwenhuijs VB, van Ramshorst B, Roos D, Rosman C, Schaapherder AF, van der Schelling GP, Timmer R, Verdonk RC, de Wit RJ, Gooszen HG, Besselink MG, van Santvoort HC; Dutch Pancreatitis Study Group.

Gastroenterology. 2019 Mar;156(4):1016-1026. doi: 10.1053/j.gastro.2018.10.045. Epub 2018 Nov 2.

PMID:
30391468
35.

International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic Cancer.

van Roessel S, Kasumova GG, Verheij J, Najarian RM, Maggino L, de Pastena M, Malleo G, Marchegiani G, Salvia R, Ng SC, de Geus SW, Lof S, Giovinazzo F, van Dam JL, Kent TS, Busch OR, van Eijck CH, Koerkamp BG, Abu Hilal M, Bassi C, Tseng JF, Besselink MG.

JAMA Surg. 2018 Dec 1;153(12):e183617. doi: 10.1001/jamasurg.2018.3617. Epub 2018 Dec 19. Erratum in: JAMA Surg. 2019 Feb 20;:.

36.

Association of the location of pancreatic ductal adenocarcinoma (head, body, tail) with tumor stage, treatment, and survival: a population-based analysis.

van Erning FN, Mackay TM, van der Geest LGM, Groot Koerkamp B, van Laarhoven HWM, Bonsing BA, Wilmink JW, van Santvoort HC, de Vos-Geelen J, van Eijck CHJ, Busch OR, Lemmens VE, Besselink MG; Dutch Pancreatic Cancer Group.

Acta Oncol. 2018 Dec;57(12):1655-1662. doi: 10.1080/0284186X.2018.1518593. Epub 2018 Sep 28.

PMID:
30264642
37.

FOLFIRINOX and radiotherapy for locally advanced pancreatic cancer: A cohort study.

Suker M, Nuyttens JJ, Groot Koerkamp B, Eskens FALM, van Eijck CHJ.

J Surg Oncol. 2018 Nov;118(6):1021-1026. doi: 10.1002/jso.25233. Epub 2018 Sep 27.

38.

Trends in treatment and survival of patients with nonresected, nonmetastatic pancreatic cancer: A population-based study.

van der Geest LGM, van Eijck CHJ, Groot Koerkamp B, Lemmens VEPP, Busch OR, Vissers PAJ, Wilmink JW, Besselink MG; Dutch Pancreatic Cancer Group.

Cancer Med. 2018 Oct;7(10):4943-4951. doi: 10.1002/cam4.1750. Epub 2018 Sep 6.

39.

Endoscopic versus percutaneous biliary drainage in patients with resectable perihilar cholangiocarcinoma: a multicentre, randomised controlled trial.

Coelen RJS, Roos E, Wiggers JK, Besselink MG, Buis CI, Busch ORC, Dejong CHC, van Delden OM, van Eijck CHJ, Fockens P, Gouma DJ, Koerkamp BG, de Haan MW, van Hooft JE, IJzermans JNM, Kater GM, Koornstra JJ, van Lienden KP, Moelker A, Damink SWMO, Poley JW, Porte RJ, de Ridder RJ, Verheij J, van Woerden V, Rauws EAJ, Dijkgraaf MGW, van Gulik TM.

Lancet Gastroenterol Hepatol. 2018 Oct;3(10):681-690. doi: 10.1016/S2468-1253(18)30234-6. Epub 2018 Aug 17.

PMID:
30122355
40.

Measurement of circulating transcript levels (NETest) to detect disease recurrence and improve follow-up after curative surgical resection of well-differentiated pancreatic neuroendocrine tumors.

Genç CG, Jilesen APJ, Nieveen van Dijkum EJM, Klümpen HJ, van Eijck CHJ, Drozdov I, Malczewska A, Kidd M, Modlin I.

J Surg Oncol. 2018 Jul;118(1):37-48. doi: 10.1002/jso.25129. Epub 2018 Aug 16.

PMID:
30114319
41.

Changes in treatment patterns and survival in elderly patients with stage I non-small-cell lung cancer with the introduction of stereotactic body radiotherapy and video-assisted thoracic surgery.

Detillon DDEMA, Driessen EJM, Aarts MJ, Janssen-Heijnen MLG, van Eijck CHJ, Veen EJ.

Eur J Cancer. 2018 Sep;101:30-37. doi: 10.1016/j.ejca.2018.06.016. Epub 2018 Jul 14.

PMID:
30014972
42.

Reference values for white blood-cell-based inflammatory markers in the Rotterdam Study: a population-based prospective cohort study.

Fest J, Ruiter R, Ikram MA, Voortman T, van Eijck CHJ, Stricker BH.

Sci Rep. 2018 Jul 12;8(1):10566. doi: 10.1038/s41598-018-28646-w.

43.

Clinical impact of the updated international postoperative pancreatic fistula definition in distal pancreatectomy.

van Hilst J, de Pastena M, de Rooij T, Alseidi A, Busch OR, van Dieren S, van Eijck CH, Giovinazzo F, Groot Koerkamp B, Marchegiani G, Marshall GR, Abu Hilal M, Bassi C, Besselink MG.

HPB (Oxford). 2018 Nov;20(11):1044-1050. doi: 10.1016/j.hpb.2018.05.003. Epub 2018 Jun 23.

44.

Management of postoperative pancreatic fistula after pancreatoduodenectomy: high mortality after completion pancreatectomy: Reply to: Bressan et al. completion pancreatectomy in the acute management of pancreatic fistula after pancreaticoduodenectomy.

Smits FJ, Molenaar IQ, Besselink MG, Busch OR, van Eijck CH, van Santvoort HC; Dutch Pancreatic Cancer Group.

HPB (Oxford). 2018 Dec;20(12):1223. doi: 10.1016/j.hpb.2018.05.015. Epub 2018 Jun 22. No abstract available.

45.

Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67.

Genç CG, Falconi M, Partelli S, Muffatti F, van Eeden S, Doglioni C, Klümpen HJ, van Eijck CHJ, Nieveen van Dijkum EJM.

Ann Surg Oncol. 2018 Aug;25(8):2467-2474. doi: 10.1245/s10434-018-6518-2. Epub 2018 May 22.

46.

New-onset diabetes after pancreatoduodenectomy: A systematic review and meta-analysis.

Scholten L, Mungroop TH, Haijtink SAL, Issa Y, van Rijssen LB, Koerkamp BG, van Eijck CH, Busch OR, DeVries JH, Besselink MG.

Surgery. 2018 May 17. pii: S0039-6060(18)30081-3. doi: 10.1016/j.surg.2018.01.024. [Epub ahead of print]

PMID:
29779868
47.

Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer.

Versteijne E, Vogel JA, Besselink MG, Busch ORC, Wilmink JW, Daams JG, van Eijck CHJ, Groot Koerkamp B, Rasch CRN, van Tienhoven G; Dutch Pancreatic Cancer Group.

Br J Surg. 2018 Jul;105(8):946-958. doi: 10.1002/bjs.10870. Epub 2018 Apr 30. Review.

48.

Successful neoadjuvant peptide receptor radionuclide therapy for an inoperable pancreatic neuroendocrine tumour.

da Silva TN, van Velthuysen MLF, van Eijck CHJ, Teunissen JJ, Hofland J, de Herder WW.

Endocrinol Diabetes Metab Case Rep. 2018 Apr 11;2018. pii: 18-0015. doi: 10.1530/EDM-18-0015. eCollection 2018.

49.

Variation in hospital mortality after pancreatoduodenectomy is related to failure to rescue rather than major complications: a nationwide audit.

van Rijssen LB, Zwart MJ, van Dieren S, de Rooij T, Bonsing BA, Bosscha K, van Dam RM, van Eijck CH, Gerhards MF, Gerritsen JJ, van der Harst E, de Hingh IH, de Jong KP, Kazemier G, Klaase J, van der Kolk BM, van Laarhoven CJ, Luyer MD, Molenaar IQ, Patijn GA, Rupert CG, Scheepers JJ, van der Schelling GP, Vahrmeijer AL, Busch ORC, van Santvoort HC, Groot Koerkamp B, Besselink MG; Dutch Pancreatic Cancer Group.

HPB (Oxford). 2018 Aug;20(8):759-767. doi: 10.1016/j.hpb.2018.02.640. Epub 2018 Mar 21.

50.

The Dutch Pancreas Biobank Within the Parelsnoer Institute: A Nationwide Biobank of Pancreatic and Periampullary Diseases.

Strijker M, Gerritsen A, van Hilst J, Bijlsma MF, Bonsing BA, Brosens LA, Bruno MJ, van Dam RM, Dijk F, van Eijck CH, Farina Sarasqueta A, Fockens P, Gerhards MF, Groot Koerkamp B, van der Harst E, de Hingh IH, van Hooft JE, Huysentruyt CJ, Kazemier G, Klaase JM, van Laarhoven CJ, van Laarhoven HW, Liem MS, de Meijer VE, van Rijssen LB, van Santvoort HC, Suker M, Verhagen JH, Verheij J, Verspaget HW, Wennink RA, Wilmink JW, Molenaar IQ, Boermeester MA, Busch OR, Besselink MG; Dutch Pancreatitis Study Group and Dutch Pancreatic Cancer Group.

Pancreas. 2018 Apr;47(4):495-501. doi: 10.1097/MPA.0000000000001018.

PMID:
29521943

Supplemental Content

Loading ...
Support Center